Sedation in ICU: Remifentanil/Propofol vs Midazolam/Fentanyl
Author Information
Author(s): Bernd Muellejans, Thomas Matthey, Joachim Scholpp, Markus Schill
Primary Institution: Heart Centre Mecklenburg-Vorpommern, Germany
Hypothesis
Patients after cardiac surgery will reach discharge criteria from the ICU sooner with remifentanil/propofol compared to midazolam/fentanyl.
Conclusion
Remifentanil-based sedation allows for earlier extubation and discharge from the ICU compared to midazolam/fentanyl, without increasing costs.
Supporting Evidence
- Patients in the remifentanil/propofol group were extubated significantly sooner than those in the midazolam/fentanyl group.
- The overall costs of ICU stay were similar for both sedation regimens.
- Remifentanil has a rapid onset and offset of action, making it suitable for short-term sedation.
Takeaway
Using remifentanil and propofol for sedation helps patients recover faster in the ICU after heart surgery.
Methodology
This was a prospective, open-label, randomised, single-centre study involving 80 patients who underwent cardiac surgery.
Potential Biases
Risk of biased patient assessment and treatment due to the open study design.
Limitations
The study was open-label, which may introduce bias, and it was conducted in a single hospital, limiting generalizability.
Participant Demographics
Patients aged 18 to 75 who underwent cardiac surgery.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website